In cellular and animal models, MOTS-c indeed appears to promote bone-forming activity
Interaction of gastric inhibitory polypeptide, glucose, and arginine on insulin and glucagon secretion from the perfused rat pancreas
Jain S, Bharal N, Khurana S, Mediratta PK, Sharma KK
Early studies show up to 24% body weight reduction, which is more than most bariatric surgeries
Reported side effects are typically mild and may include: Mild nausea (usually with oral forms) Temporary dizziness Gastrointestinal discomfort Injection site reactions (with injectable form) Most users report no significant side effects, making it an attractive option for those concerned about adverse reactions to traditional medications
01 40-60% greater healing outcomes 02 Simultaneous activation of early-phase 03 Synergistic upregulation of both Recovery & Healing Our most popular blend combines BPC-157 and TB-500 in optimized ratios for thorough tissue repair